TUSNEL C- codeine phosphate, guiafenesin, pseudoephedrine hcl liquid
Llorens Pharmaceutical International Division
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Active Ingredients(in each 5 ml tsp.) Purpose
Codeine Phosphate ................................................. 10 mg .......... Cough Suppressant
Guaifenesin .......................................................... 100 mg .................. Expectorant
Pseudoephedrine HCl ............................................. 30 mg .......... Nasal Decongestant
Warnings
Do not use if you are now taking a prescription monoamine oxidase
inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional
conditions, or Parkinson’s disease), or for 2 weeks after stopping the
MAOI drug. If you do not know if your prescription drug contains an
MAOI, ask a doctor or pharmacist before taking this product.
When using this product
do nol exceed recommended dosage
• may cause or aggravate constipation
Keep out of reach of children. In case of overdose, get medical helpor contact a Poison Control Center right away.
Directions: Follow dosage chartDosage may be repeated every 6 hours. Not to exceed 4 doses in 24-hours. Giving a higher dose
than recommended by a doctor could result in serious side effects for your child. A special measuring
device should be used to give an accurate dose of this product to children under 6 years of age.
Age | Weight | Dose |
children 12 years of age and over | 95 lbs and up | Take 2 teaspoonfuls (10 mL) every 6 hours |
Children 6 to under 12 years of age | 45 lbs to under 95 lbs | Take 1 teaspoonful (5mL) every 6 hours |
Children under 6 years of age | under 45 lbs | ask a doctor |
TUSNEL
C
codeine phosphate, guiafenesin, pseudoephedrine hcl liquid |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Llorens Pharmaceutical International Division (037342305) |